XML 48 R36.htm IDEA: XBRL DOCUMENT
v3.23.2

Acquisitions (Tables) | 6 Months Ended
--- | ---
Jun. 30, 2023
Business Combination and Asset Acquisition [Abstract] |
Schedule of purchase price allocation | The following table summarizes the consideration paid for the BioPhero acquisition and the amounts of the assets acquired and liabilities assumed.
Purchase Price Allocation
(in Millions) |
Fair Value of Assets Acquired |
Cash | $ | 10.0 |
Intangible assets |
Developed Technology (1) | 66.3 |
In-process research & development | 10.5 |
Goodwill | 130.7 |
Other Assets | 3.4 |
Total Assets | $ | 220.9 |
Fair Value of Liabilities Assumed |
Deferred income tax liabilities | $ | 16.6 |
Other Liabilities | 1.1 |
Total Liabilities | 17.7 |
Net Assets | $ | 203.2 |
Total Purchase Consideration: | Amount
Cash purchase price, net of acquired cash | $ | 193.2 |
____________________ |
(1) Expected life is 15 years and will be amortized based on the pattern of economic benefit |

X
- References No definition available. + Details
Name: | us-gaap_BusinessCombinationAndAssetAcquisitionAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 805 -SubTopic 20 -Name Accounting Standards Codification -Paragraph 1 -Section 50 -Publisher FASB -URI https://asc.fasb.org//1943274/2147479907/805-20-50-1 + Details
Name: | us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration